Cetera Advisor Networks’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,220
| Closed | -$234K | – | 2803 |
|
|
2023
Q4 | $234K | Sell |
1,220
-185
| -13% | -$35.4K | ﹤0.01% | 2417 |
|
|
2023
Q3 | $249K | Sell |
1,405
-77
| -5% | -$13.6K | ﹤0.01% | 2271 |
|
|
2023
Q2 | $281K | Sell |
1,482
-165
| -10% | -$31.3K | ﹤0.01% | 2128 |
|
|
2023
Q1 | $330K | Buy |
1,647
+9
| +0.5% | +$1.8K | ﹤0.01% | 1990 |
|
|
2022
Q4 | $389K | Buy |
+1,638
| New | +$389K | ﹤0.01% | 1816 |
|
|
2022
Q3 | – | Sell |
-4,853
| Closed | -$708K | – | 2081 |
|
|
2022
Q2 | $708K | Buy |
4,853
+554
| +13% | +$80.8K | 0.01% | 1062 |
|
|
2022
Q1 | $702K | Buy |
4,299
+1,313
| +44% | +$214K | 0.01% | 1102 |
|
|
2021
Q4 | $506K | Buy |
2,986
+225
| +8% | +$38.1K | 0.01% | 1273 |
|
|
2021
Q3 | $521K | Buy |
2,761
+696
| +34% | +$131K | 0.01% | 1201 |
|
|
2021
Q2 | $350K | Buy |
+2,065
| New | +$350K | ﹤0.01% | 1396 |
|